Cargando…

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

BACKGROUND: T cell immunoglobulin mucin-3 (Tim-3) has been identified as a negative regulator of anti-tumor immunity. Recent studies highlight the important role of Tim-3 in the CD8(+) T cell exhaustion that takes place in both human and animal cancer models. However, the nature of Tim-3 expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yang, Zhou, Xiaoxi, Huang, Xiaoyuan, Li, Qinlu, Gao, Lili, Jiang, Lijun, Huang, Mei, Zhou, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545875/ https://www.ncbi.nlm.nih.gov/pubmed/23335978 http://dx.doi.org/10.1371/journal.pone.0053834

Ejemplares similares

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
por: Huang, Xiaoyuan, et al.
Publicado: (2010)

Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
por: Huang, Xiaoyuan, et al.
Publicado: (2021)

TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
por: Chen, Liuyan, et al.
Publicado: (2022)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

TIM-1 Promotes Japanese Encephalitis Virus Entry and Infection
por: Niu, Jichen, et al.
Publicado: (2018)

N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
por: Chen, Siyuan, et al.
Publicado: (2022)

TIM-3 expression in breast cancer
por: Burugu, Samantha, et al.
Publicado: (2018)

Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
por: Wang, Yaping, et al.
Publicado: (2020)

TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
por: Gao, Xin, et al.
Publicado: (2012)

Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
por: Yu, Muming, et al.
Publicado: (2017)

Tim-3 Expression Defines Regulatory T Cells in Human Tumors
por: Yan, Jing, et al.
Publicado: (2013)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Tumor‐derived endomucin promotes colorectal cancer proliferation and metastasis
por: Huang, Qi, et al.
Publicado: (2022)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)

On the significance of Tim-3 expression in pancreatic cancer
por: Peng, Pu-ji, et al.
Publicado: (2017)

IL‐6 promotes metastasis of non‐small‐cell lung cancer by up‐regulating TIM‐4 via NF‐κB
por: Liu, Wen, et al.
Publicado: (2020)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications
por: Li, Yuting, et al.
Publicado: (2023)

DIPG-04. TUMOR CELL-INTRINSIC TIM-3 PROMOTES DIFFUSE INTRINSIC PONTINE GLIOMA TUMORIGENESIS
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2023)

Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis
por: Chen, Lingli, et al.
Publicado: (2021)

Tim-3 Expression and MGMT Methylation Status Association With Survival in Glioblastoma
por: Zhang, Ji, et al.
Publicado: (2020)

Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells
por: Cong, Yizi, et al.
Publicado: (2020)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Prognostic value of TIM-1 expression in human non-small-cell lung cancer
por: Zheng, Xiao, et al.
Publicado: (2019)

Dysregulated T cell expression of TIM3 in multiple sclerosis
por: Koguchi, Ken, et al.
Publicado: (2006)

Tim-3 expression and its role in hepatocellular carcinoma
por: Liu, Feifei, et al.
Publicado: (2018)

Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study
por: Zhang, Chi, et al.
Publicado: (2023)

TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer
por: Katagata, Masanori, et al.
Publicado: (2023)

TIM-4 is expressed on invariant NKT cells but dispensable for their development and function
por: Zhang, Xilin, et al.
Publicado: (2016)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer
por: Liu, Pan, et al.
Publicado: (2020)

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2023)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4k6vp8cc39en9nugfvptooeqch